Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-24
    E.g., 2018-09-24

Articles

51716 items
12:00 AM, Sep 29, 2000  |  BC Extra | Politics & Policy

Trade organizations try to derail re-import initiatives

Trade associations representing the biotech and pharmaceutical industries launched late-stage efforts Friday to derail politically popular initiatives to allow re-importation of FDA-approved drugs. The Republican congressional leadership and President Clinton agreed earlier this week to...
12:00 AM, Sep 29, 2000  |  BC Extra | Company News

Xenogen to acquire DNX

Xenogen (Alameda, Calif.) will acquire MDS's DNX Transgenic Sciences subsidiary in a stock transaction. DNX (Cranbury, N.J.) is a contract research organization (CRO) providing transgenic animal technologies. Xenogen said the acquisition will expand the applications...
12:00 AM, Sep 29, 2000  |  BC Extra | Company News

American Red Cross ends supply deal with HemaSure

HMSR said the Red Cross is terminating its 1999 three-year supply contract for HMSR's r/LS Red Blood Cell Filtration System that reduces leukocyte counts in donated blood (see BioCentury, Aug. 2, 1999). In April,...
12:00 AM, Sep 29, 2000  |  BC Extra | Financial News

Eden sells shoe

Ag biotech company EDEN raised $13.1 million through the sale of 870,000 shares at $15 authorized to cover overallotments in its September IPO. The sale brings to $100.1 million the total raised in the deal,...
12:00 AM, Sep 29, 2000  |  BC Extra | Financial News

OSIP files for follow-on

OSI Pharmaceuticals, a developer of gene-targeted small molecule drugs, filed to sell 4.5 million shares in a follow-on. The offering, which has a 675,000-share overallotment, will be underwritten by Robertson Stephens; Lehman Brothers; Prudential Vector;...
12:00 AM, Sep 29, 2000  |  BC Extra | Financial News

Genomica raises $122.4 million

Genomica (GNOM, Boulder, Colo.) raised $122.5 million in an IPO of 6.44 million shares at $19. The offering, which has a 966,000-share overallotment, was underwritten by CIBC World Markets; Dain Rauscher Wessels; and Prudential Vector...
12:00 AM, Sep 29, 2000  |  BC Extra | Financial News

Corvas files for follow-on

CVAS a filed to sell 5 million shares in a follow-on underwritten by CIBC World Markets; Prudential Vector; and U.S. Bancorp Piper Jaffray. The offering has a 750,000-share overallotment. The company is developing therapeutics for...
12:00 AM, Sep 29, 2000  |  BC Extra | Top Story

NBAC on clinical trial ethics

Fundamental ethical principles should govern clinical research, regardless of the social and economic conditions of the countries in which it is conducted, according to a report issued by the National Bioethics Advisory Commission on Friday....
12:00 AM, Sep 29, 2000  |  BC Extra | Company News

Sequenom sells four MassArray systems

SQNM sold its MassArray single nucleotide polymorphism (SNP) analysis systems to four more partners. Hitachi (HIT) will use the MassArray for internal SNP marker validation and to provide genotyping services to the Japanese SNP analysis...
12:00 AM, Sep 29, 2000  |  BC Extra | Financial News

PowderJect raises 35.3 million

PowderJect (LSE:PJP) raised 35.3 million ($51.5 million) through the placing and open offer of 5.9 million shares at 600p. The amount raised will be used towards the financing of its acquisition of the Medeva Vaccines...

Pages